Skip to main content
Rino Seedor, MD, Oncology, Philadelphia, PA, Thomas Jefferson University Hospital

RinoSeedorMD

Oncology Philadelphia, PA

Melanoma

Assistant professor at Sidney Kimmel Cancer Center at Jefferson Health

Dr. Seedor is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Seedor's full profile

Already have an account?

Summary

  • I am a medical oncologist specializing in cutaneous and ocular melanoma as well as non-melanoma skin cancers. I completed my medical school and residency training at Jefferson, and then completed my hematology/oncology training at Fox Chase Cancer Center/Temple University Hospital.

Education & Training

  • Temple University Hospital/Fox Chase Cancer Center
    Temple University Hospital/Fox Chase Cancer CenterFellowship, Hematology and Medical Oncology, 2021
  • Sidney Kimmel Medical College at Thomas Jefferson University/TJUH
    Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 2015 - 2018
  • Sidney Kimmel Medical College at Thomas Jefferson University
    Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2015

Certifications & Licensure

  • DE State Medical License
    DE State Medical License Current
  • NJ State Medical License
    NJ State Medical License 2022 - 2025
  • PA State Medical License
    PA State Medical License 2015 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Journal Articles

  • Treatment of Metastatic Melanoma in the Elderly  
    Rino S. Seedor and Marlana Orloff, Current Oncology Reports, 3/22/2022
  • Case Report: Cytarabine-Induced Pericarditis and Pericardial Effusion  
    Sato R., and Park, R., The Thomas Jefferson Medicine Forum, 2017
  • Fatal Rituximab-Induced Nonspecific Interstitial Pneumonia: Case Report and Review of the Literature  
    Sato, R., Molligan J., and Gaballa, S., The Thomas Jefferson Medicine Forum, 2017

Abstracts/Posters

  • The prevalence of hereditary pancreatitis mutations in families with pancreatic cancer.
    Seedor, R. S., Savage, M. J., Iqbal, W., Arora, S., Rainey, K., Forman, A., Lincoln, S., Garcia, J., Truty, R., Esplin, E. D., Handorf, E. A., and Hall, M. J., 2019 ASCO Annual Meeting.
  • Clinical Trial in Progress: Phase II trial of defactinib (VS-6063) combined with VS-6766 (CH5126766) in patients with metastatic uveal melanoma.
    Seedor, R. S., Orloff, M., Gutkind, J. S., Aplin, A., Terai, M., Sharpe-Mills, E., Klose, H., Mastrangelo, M. J., and Sato, T., 2021 Virtual ASCO Annual Meeting, 6/4/2021
  • Prospective study comparing self-administered geriatric assessment to provider’s routine clinical assessment of older patients with metastatic breast cancer treated at...
    Seedor, R. S., Meeker, C. R., Lewis, B., Handorf, E. A., Filchner, K. A., Winn, J., Goldstein, L. J., and Dotan, E., 2020 Virtual ASCO Annual Meeting, 5/29/2020
  • Join now to see all

Other

Press Mentions

  • Metastatic Uveal Melanoma: New Drugs in Pipeline, but Prognoses Remain Grim
    Metastatic Uveal Melanoma: New Drugs in Pipeline, but Prognoses Remain GrimDecember 14th, 2021

Hospital Affiliations